yttrium radioisotopes has been researched along with Arterial Occlusive Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hsu, MJ; Padia, SA; Srinivasa, RN; Tran, DN | 1 |
Campbell, JM; Cash, C; Chehab, M; Savin, JH; Savin, MA; Schultz, CC; Wong, CY | 1 |
Bantleon, R; Bayer, M; Claussen, CD; Dittmann, H; Kehlbach, R; Landers, A; Pritzkow, M; Sauter, A; Schmehl, J; Wiesinger, B | 1 |
Fox, RA | 1 |
4 other study(ies) available for yttrium radioisotopes and Arterial Occlusive Diseases
Article | Year |
---|---|
Transsplenic Arterial Radioembolization of Hepatic Metastases in a Patient with Celiac Artery Occlusion.
Topics: Aged; Arterial Occlusive Diseases; Catheterization, Peripheral; Celiac Artery; Constriction, Pathologic; Embolization, Therapeutic; Humans; Liver Neoplasms; Male; Prostatic Neoplasms; Radiography, Interventional; Radiopharmaceuticals; Splenic Artery; Treatment Outcome; Yttrium Radioisotopes | 2019 |
Yttrium-90 Infusion: Incidence and Outcome of Delivery System Occlusions during 885 Deliveries.
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Catheterization, Peripheral; Causality; Comorbidity; Equipment Failure; Female; Humans; Incidence; Infusions, Intra-Arterial; Liver Neoplasms; Male; Michigan; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Treatment Failure; Treatment Outcome; Young Adult; Yttrium Radioisotopes | 2015 |
A dual-inhibition study on vascular smooth muscle cells with meclofenamic acid and β-irradiation for the prevention of restenosis.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Brachytherapy; Cell Cycle; Cell Movement; Cell Proliferation; Cells, Cultured; Combined Modality Therapy; Constriction, Pathologic; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Humans; Meclofenamic Acid; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Secondary Prevention; Time Factors; Yttrium Radioisotopes | 2011 |
Dosimetry of beta emitting radionuclides for use in balloon angioplasty.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Arteries; Beta Particles; Humans; Phosphorus Radioisotopes; Radioisotopes; Radiotherapy Dosage; Rhenium; Yttrium Radioisotopes | 1997 |